Metabolic Diseases

Interconnected cardiovascular, renal and metabolic (CRM) diseases account for 1 in 4 deaths annually in Australia. Building on our expertise in developing innovative treatments for a range of cardiovascular and metabolic conditions, our R&D approach in cardiometabolic diseases takes a holistic view on the therapeutic needs of people affected by multiple, related cardiovascular and metabolic conditions.

_PC-AU-10884